Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06682975 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 17, 2026 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2025 to Aug 2026v3 Show 4 more changesShow less
    • Enrollment target: 92 to 124
    • Eligibility criteria revised
    • Study description expanded, about 30 words
    • Study title expanded, about 2 words
  2. Start date changed from estimate of Nov 2024 to Nov 12, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Zealand Pharma
13 trials monitored
See 1 trial at risk
The primary object in this research study is to investigate the safety and tolerability of ZP9830 in healthy study participants, and in addition, the study will investigate how ZP9830 works in the body (pharmacokinetics, PK and pharmacodynamics, PD) compared to placebo.
Trial Details
NCT Number NCT06682975
Lead Sponsor Zealand Pharma
Conditions
(from sponsor)		 Healthy Volunteers
Enrollment 124 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov